Description: Elixinol Wellness Limited, through its subsidiaries, engages in the manufacture and distribution of hemp derived nutraceuticals, skincare, and food products in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.
Home Page: www.elixinolwellness.com
680 George Street
Sydney,
NSW
2000
Australia
Phone:
61 2 8280 7355
Officers
| Name | Title |
|---|---|
| Ms. Josephine Mary Lorenz | Group Chief Financial Officer |
| Glen Zurcher | Account Director of Investor Relations Department |
| Ms. Natalie Butler | Head of Marketing & Executive Director |
| Ms. Melanie Leydin | Company Secretary |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.1936 |
| Price-to-Sales TTM: | 0.0506 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |